# Magnesium Bisglycinate

> Magnesium bisglycinate is magnesium chelated to two glycine molecules, the form with the best absorption and the cleanest gut profile for mast-cell-sensitive patients. It stabilizes mast cells by competing at calcium channels, supports HRV in POTS, and serves as a foundational electrolyte. ZebraThrive uses 300 mg elemental daily (from 2,400 mg bisglycinate) in the Daily Powder, split AM and PM.

**Page:** https://www.wellnessforzebras.com/ingredients/magnesium-bisglycinate
**Brand:** ZebraThrive
**Author:** Ken Chapman, Founder of ZebraThrive
**Last reviewed:** 2026-05-11
**Daily dose:** 300 mg elemental magnesium daily from 2,400 mg magnesium bisglycinate, in the Daily Powder, split AM and PM scoops (per v7.8 RFQ)
**Form used:** Magnesium Glycinate
**Target population:** Adults 18+ with hypermobile Ehlers-Danlos Syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), or Mast Cell Activation Syndrome (MCAS).
**Regulatory framing:** US DSHEA dietary supplement. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

## Key benefits

- Mast cell stabilizer: Reduces degranulation in dose-dependent manner
- Calcium channel competition: dampens mast cell degranulation by limiting calcium influx
- Correction of deficiency: 75% of POTS patients are deficient
- Glycine byproduct supports sleep and collagen

## What it is

A highly absorbable, gentle form of magnesium bound to the amino acid glycine

## Why we include it

Magnesium is a foundational mineral for mast cell stability, autonomic function, and as a cofactor for histamine degradation (DAO enzyme)

## Plain-language summary

Magnesium bisglycinate is magnesium bonded to two glycine amino acids - a gentle form that absorbs well without the laxative effect you get from cheaper magnesium forms like oxide or citrate. For the EDS/POTS/MCAS triad, magnesium is foundational. Most people in this community run low on it, and being low triggers mast cell instability, sympathetic overdrive, and lousy sleep. The bisglycinate form has the cleanest gut profile and the best human trial data for sleep quality and heart rate variability. We chose it over magnesium oxide (barely absorbed) and threonate (more expensive without the across-the-board benefits).

## Mechanism

Magnesium is involved in over 300 enzymatic reactions. In the triad, three functions matter most.

First, magnesium stabilizes mast cells by competing at calcium channels. Mast cell degranulation is triggered by calcium influx; adequate magnesium dampens that influx. A 2025 in vitro study showed magnesium reduces mast cell degranulation in a dose-dependent manner. Magnesium deficiency does the opposite: in animal data, deficient rats run 4-5 fold higher blood histamine within two weeks.

Second, magnesium modulates the autonomic nervous system. It supports parasympathetic ("rest and digest") tone and improves heart rate variability. For POTS specifically, this matters because autonomic instability is the core mechanism of the condition.

Third, the bisglycinate form delivers ~2g of glycine daily as a useful byproduct. Glycine supports sleep architecture and is a primary amino acid in collagen synthesis. DAO itself, the enzyme that degrades histamine in the gut, is copper-dependent rather than magnesium-dependent; magnesium's contribution to histamine handling is upstream, through the calcium-channel and deficiency-correction mechanisms above.

## Condition-specific notes

### MCAS (Mast Cell Activation Syndrome)

Magnesium stabilizes mast cells directly by competing at calcium channels and corrects the deficiency state that drives mast cell hyperreactivity (animal data shows 4-5 fold increased histamine in deficient states). Glycinate is preferred because it is not fermentation-derived (unlike citrate, which carries histamine risk in MCAS-sensitive patients).

### hEDS (hypermobile Ehlers-Danlos Syndrome)

Magnesium may provide collagen protection through MMP inhibition. The glycine byproduct serves as a building block for collagen. It also supports muscle relaxation, helping with spasms common in hEDS.

### POTS (Postural Orthostatic Tachycardia Syndrome)

75% of POTS patients have magnesium deficiency. Magnesium improves heart rate variability and supports parasympathetic tone. Monitor blood pressure in hypotensive POTS patients as it can lower BP slightly.

## Why this form

**Selected form:** Magnesium Glycinate

Form selection matters for absorption and MCAS tolerability. We chose glycinate because it uses the PEPT1 dipeptide pathway, causes minimal GI upset, is NOT fermentation-derived, and provides beneficial glycine.

**Form comparison:**

| Form | Notes | Selected |
|---|---|---|
| Magnesium oxide | Only 4-15% absorption; strong laxative effect | No |
| Magnesium citrate | ~30% absorption; fermentation-derived = histamine risk | No |
| Magnesium glycinate | High absorption; minimal GI upset; glycine benefits | Yes |
| Magnesium L-threonate | Brain-penetrant alternative for cognitive symptoms; not what we ship | No |

## Dose protocol

| Step | Dosage | Notes |
|---|---|---|
| Week 1 | 100 mg elemental | MCAS ultra-sensitive start |
| Week 2 | 125 mg twice daily | Standard start |
| Week 3 | 150 mg twice daily | Target maintenance |
| Week 4+ | 300 mg elemental daily | Full therapeutic dose, split AM/PM |

**Timeline to effect:** RBC magnesium repletion requires 8-12 weeks. Don't expect immediate effects-repletion takes time. Sleep benefits may appear within 2-4 weeks.

## Evidence summary

### Mast Cell Stabilization

Recent research provides definitive evidence that magnesium stabilizes-not activates-mast cells.

- [1] **Kazama I et al., "Magnesium and zinc stabilize mast cells".** Design: In vitro study using rat peritoneal mast cells (2025). Finding: Magnesium chloride reduced degranulating mast cells in a dose-dependent manner-first definitive in vitro evidence. PMID: 40692390.
- [2] **Srebro D et al., "Magnesium in orofacial pain model".** Design: In vivo rat model (2023). Finding: Magnesium reduced mast cell degranulation by ~23% in acute phase and ~40% in second phase. PMID: 37047214.

### Autonomic Function and HRV

Magnesium supplementation improves heart rate variability and autonomic balance.

- [3] **Almoznino-Sarafian D et al., "Magnesium and heart rate variability".** Design: Controlled trial, 32 heart failure patients, 300 mg/day. Finding: HRV correlation dimension significantly improved from 3.47 to 3.94 (p<0.001). PMID: 19201586.

### Deficiency and Consequences

Magnesium deficiency triggers mast cell activation and is extremely common in this population.

- [5] **Kraeuter SL & Schwartz R, "Magnesium deficiency and histamine".** Design: Animal model of magnesium depletion. Finding: Magnesium-depleted rats showed 4-5 fold increased blood histamine by day 14 with massive degranulation. PMID: 6445415.

## Evidence gaps

No randomized controlled trials exist specifically testing magnesium glycinate in hEDS, POTS, or MCAS. One hEDS study found 59/94 patients had low RBC magnesium. Despite limited trials, 61-81% of hEDS patients report taking magnesium, reflecting widespread clinical use.

## Safety

**Side effects:** Magnesium glycinate is the best-tolerated form for GI-sensitive patients. Diarrhea can occur if dose is increased too rapidly. Theoretical concern of hypotension exists but is usually not significant in normotensive populations.

**Interactions:** Antibiotics: Space by 2-6 hours. Bisphosphonates: Separate by 2+ hours. Thyroid medications: Space 2-4 hours. Fludrocortisone: Monitor electrolytes.

**Cautions:** Monitor blood pressure when initiating. Kidney function should be normal. Paradoxical reactions occur in 25-30% of MCAS patients; try a different form if this happens.

**Excipients to avoid:** Fermentation-derived citrate, Magnesium stearate, Artificial colors

**Excipients that are safe:** Magnesium glycinate from Albion chelate, Powder form (eliminates fillers)

## Frequently asked questions

### Why not magnesium oxide - it's cheaper?

Because most of it never gets into your bloodstream. Magnesium oxide is about 4-10% bioavailable - most of it pulls water into your colon and you find out 30 minutes later. Bisglycinate is 20-40% bioavailable, absorbed through a different transporter (PepT1) that bypasses the laxative pathway. The glycine portion also has its own modest calming and sleep-supporting effects. For anyone with gastroparesis or a sensitive gut, bisglycinate is the only form that makes sense.

### Will magnesium drop my blood pressure?

For most POTS patients, no. The most recent meta-analysis (2,700+ people) found magnesium had essentially no significant blood pressure effect in people with normal BP. The 'magnesium lowers BP' framing came from older studies in hypertensive populations. If you're already on midodrine and running low, give your prescriber a heads-up - but the data doesn't support magnesium as a meaningful BP dropper at the doses we use.

### How does magnesium help with mast cells?

Two ways. First, magnesium directly stabilizes mast cells by competing at the calcium channels that trigger degranulation, with lab studies showing a clear dose-dependent effect. Second, magnesium deficiency by itself activates mast cells: deficient rats run 4-5x normal blood histamine within two weeks, so correcting low magnesium removes a major upstream trigger. DAO itself, the enzyme that breaks down histamine in your gut, is primarily copper-dependent rather than magnesium-dependent, so magnesium's contribution to histamine handling works through these upstream mechanisms rather than as a direct DAO cofactor.

### How long until I notice anything?

Sleep onset can improve within the first week - meta-analysis data shows sleep latency drops by about 17 minutes on average. Heart rate variability changes typically take 4-12 weeks to register on a wearable. The deeper benefits - calmer baseline stress, fewer cramps, better autonomic stability - develop over months as your cellular magnesium stores refill. Blood tests for magnesium are notoriously unreliable (only about 1% of body magnesium is in your blood), so don't go by serum levels.

## References

[1] Kazama I et al.. (2025). Magnesium and zinc stabilize mast cells in a dose-dependent manner. PMID: 40692390. https://pubmed.ncbi.nlm.nih.gov/40692390/
[2] Srebro D et al.. (2023). Magnesium reduces mast cell degranulation in orofacial pain model. PMID: 37047214. https://pubmed.ncbi.nlm.nih.gov/37047214/
[3] Almoznino-Sarafian D et al.. (2009). Magnesium administration and heart rate variability. PMID: 19201586. https://pubmed.ncbi.nlm.nih.gov/19201586/
[4] Schuette SA et al.. (1994). Bioavailability of magnesium diglycinate vs magnesium oxide. PMID: 7815675. https://pubmed.ncbi.nlm.nih.gov/7815675/
[5] Kraeuter SL & Schwartz R, "Magnesium deficiency and histamine". PMID: 6445415. https://pubmed.ncbi.nlm.nih.gov/6445415/